A Phase 1, Open-label, Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

  • McMahon, James (Primary Chief Investigator (PCI))
  • Roney, Janine (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date28/09/22 → 31/12/23

Keywords

  • Clinical trial
  • COVID-19
  • Immune response
  • mRNA vaccine